Increasing competition in pharmaceutical tenders: Patents, treatment guidelines, and centralised procurement of Hepatitis C drugs in Brazil. [PDF]
Mercadante E.
europepmc +1 more source
Unravelling HCV diversity and resistance in Viet Nam: a cross-sectional analysis. [PDF]
Le Ngoc C +24 more
europepmc +1 more source
Outcomes After 4-Week Course of Sofosbuvir/Velpatasvir Therapy in Hepatitis C Seronegative Recipients of Kidneys From Hepatitis C Viremic Deceased Donors. [PDF]
Kummangal BA +10 more
europepmc +1 more source
Direct-Acting Antivirals in Patients with Comorbidities for the Simplified Management of HCV Infection: An Expert Review with a Focus on Sofosbuvir-Velpatasvir. [PDF]
Aghemo A +6 more
europepmc +1 more source
Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023. [PDF]
Suoh M, Esmaili S, Eslam M, George J.
europepmc +1 more source
Navigating Therapeutic Frontiers: A Meta-review and Meta-analysis of COVID-19 Treatment Options. [PDF]
Mousavi S, Ardekani MB, Feizi A.
europepmc +1 more source
Hepatitis C in Chronic Kidney Disease After the DAA Revolution: Clinical Decisions, Transplantation, and Implementation Challenges. [PDF]
Mohrag M +3 more
europepmc +1 more source
Hepatitis C in the Direct-Acting Antiviral Era: Immunopathogenesis, Dendritic Cells and Modern Clinical Management. [PDF]
Kurmangaliyeva K +7 more
europepmc +1 more source
Human Pegivirus Encephalitis With Brain Detection and Response to Sofosbuvir Ledipasvir. [PDF]
Moulignier A +3 more
europepmc +1 more source
Hepatitis C Virus Infection in the PERSIAN Guilan Cohort Study Population: Intrafamilial Transmission Incidence and Response to SOVODAK-Based Therapy. [PDF]
Joukar F +3 more
europepmc +1 more source

